Photo: Close up of researcher using a pippette

Ibudilast

Ibudilast (also known as MN-166) is being developed for progressive MS by MediciNova. It is currently in phase 2 clinical trials.

Current phase of trial: Phase 2

Type of MS: Progressive MS

Find out more about ibudilast